Metraipolis › archive › dc_3e7f308bccf5
Assessing the Growing Impact of Oral GLP-1 Agonists on National Obesity Policies of the United Kingdom — Europe PMC PMID:42746314
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42746314
- DOI
- 10.7759/cureus.116274
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-10T02:13:39.933Z
- SHA-256 of the archived text
8fa9e51447c1e2d9448cb6cee515a1863d50d3d824156417ef39d9c7e79e22f9- Stable URL of this page
https://metraipolis.com/documento/dc_3e7f308bccf5
How to cite
Assessing the Growing Impact of Oral GLP-1 Agonists on National Obesity Policies of the United Kingdom — Europe PMC PMID:42746314 — Europe PMC (en), https://europepmc.org/article/MED/42746314 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3e7f308bccf5 (Metraipolis archive dc_3e7f308bccf5, sha256 8fa9e51447c1e2d9448cb6cee515a1863d50d3d824156417ef39d9c7e79e22f9)
BibTeX
@misc{dc3e7f308bccf5,
title = {Assessing the Growing Impact of Oral GLP-1 Agonists on National Obesity Policies of the United Kingdom — Europe PMC PMID:42746314},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42746314},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3e7f308bccf5; sha256 8fa9e51447c1e2d9448cb6cee515a1863d50d3d824156417ef39d9c7e79e22f9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42746314. Agents can read the archived copy with the MCP tool read_document.